Researchers are excited about the medication , a innovative dual treatment showing promising results in early trials for weight reduction . It functions by modulating several pathways : GLP-1 and GIP, which , when stimulated, assist control appetite and enhance energy expenditure . Early observations indicate considerable body management and possib